Nano-X Imaging (NNOX) Total Current Liabilities (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Total Current Liabilities of $14.1 million for Q1 2026, up 10.03% year-on-year from $12.8 million in Q1 2025, and down 16.4% on a QoQ basis from $16.9 million in Q4 2025.
Nano-X Imaging (NNOX) Total Current Liabilities (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Total Current Liabilities for 8 consecutive years, with $14.1 million the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities rose 10.03% year-over-year to $14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.1 million (up 10.03% YoY) and the FY2025 annual result came in at $16.9 million, up 20.87% from the prior year.
- Total Current Liabilities slipped to $14.1 million in Q1 2026 per NNOX's latest filing, from $16.9 million in the prior quarter.
- Over the last five years, Total Current Liabilities for NNOX reached as high as $51.0 billion in Q1 2022 and fell as low as $12.4 million in Q3 2025.
- A 5-year average of $8.0 billion and a median of $15.5 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 758294.02% — and 2023, when it sank 99.95%.
- Year by year, Total Current Liabilities stood at $25.1 million in 2022, then sank by 38.09% to $15.5 million in 2023, then decreased by 10.0% to $14.0 million in 2024, then grew by 20.87% to $16.9 million in 2025, then retreated by 16.4% to $14.1 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $14.1 million, $16.9 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | 14.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.12 Mn |
| Dec 31, 2025 | 16.89 Mn |
| Sep 30, 2025 | 12.39 Mn |
| Jun 30, 2025 | 13.71 Mn |
| Mar 31, 2025 | 12.83 Mn |
| Dec 31, 2024 | 13.97 Mn |
| Sep 30, 2024 | 13.03 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 13.61 Mn |
| Dec 31, 2023 | 15.52 Mn |
| Sep 30, 2023 | 20.04 Mn |
| Jun 30, 2023 | 23.43 Mn |
| Mar 31, 2023 | 24.17 Mn |
| Dec 31, 2022 | 25.07 Mn |
| Sep 30, 2022 | 43.59 Bn |
| Jun 30, 2022 | 40.61 Bn |
| Mar 31, 2022 | 51.05 Bn |
| Dec 31, 2021 | 52.75 Mn |
| Sep 30, 2021 | 6.22 Mn |
| Jun 30, 2021 | 5.36 Mn |